but less with valsartan than with amlodipine, particularly during the first 6 months. The two groups did not differ in the primary composite endpoint of adverse cardiovascular events. However ...
OBJECTIVE: To examine in patients treated with a regimen including single-pill combinations (SPCs) of amlodipine/valsartan (1) blood pressure (BP) reduction and control, total cardiovascular risk ...
Amlodipine, commonly known as Norvasc, is a calcium channel blocker medication that is approved by the Food and Drug Administration (FDA) to treat high blood pressure, chest pain, and coronary ...
The US Court of Appeals for the Federal Circuit has reversed the New Jersey District Court's dismissal of Pfizer's patent infringement action against Dr Reddy's Laboratories' generic version of ...